EMA's human medicines committee said it has recommended granting a conditional marketing authorization to remdesivir for the treatment of COVID-19 in adults and adolescents from 12 years of age who are suffering pneumonia and require extra oxygen.
It said its assessment was based mainly based on data from a study sponsored by the US National Institute of Allergy and Infectious Diseases . The research, published in the leading journal the New England Journal of Medicine in May, showed that injections of remdesivir speeded patient recovery compared with a placebo.One study published in The Lancet, however, found no"significant clinical benefit" from treating coronavirus patients with remdesivir.
"Taking into consideration the available data, the agency considered that the balance of benefits and risks had been shown to be positive in patients with pneumonia requiring supplemental oxygen; i.e., the patients with severe disease," the Amsterdam-based EU agency said. –
Huwag na ipaalam yan sa DOH habang diayan si DOQUE kontrahin agad yan kahit libo libo na mamatay isa nalang naniwala ni DOQUE si DUTERTE. Ubusin lang billion budget sa DOH tapus walang mangyari iisa lang paraan mawala si DOQUE sa DOH kung mamatay yan, piro kung masibak, malabo.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: rapplerdotcom - 🏆 4. / 86 Read more »